Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 6:46 pm Sale | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | BCLS II Equity Opportunities LP | 0 0.000% | -213,908 (Position Closed) | Filing History |
| 2024-02-13 5:28 pm Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Montanova Capital, LLC | 412,395 1.000% | 157,340 (+61.69%) | Filing History |
| 2024-02-13 4:48 pm Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Affinity Asset Advisors, LLC | 653,409 1.810% | 354,329 (+118.47%) | Filing History |
| 2024-02-13 09:39 am Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Polar Capital Holdings Plc | 500,000 1.050% | 342,552 (+217.57%) | Filing History |
| 2024-02-12 12:03 pm Purchase | 2024-02-09 | 13G | SPYRE THERAPEUTICS, INC SYRE | FMR LLC | 6,206,451 13.065% | 2,420,574 (+63.94%) | Filing History |
| 2024-02-09 10:20 am Purchase | 2024-02-08 | 13G | SPYRE THERAPEUTICS, INC SYRE | FMR LLC | 3,785,877 7.969% | 3,785,877 (New Position) | Filing History |
| 2024-02-08 4:36 pm Sale | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Integrated Core Strategies (US) LLC | 108,486 0.300% | -16,773 (-13.39%) | Filing History |
| 2023-12-29 5:00 pm Sale | 2023-12-29 | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 836,459 2.320% | -2,977,442 (-78.07%) | Filing History |
| 2023-12-13 3:50 pm Purchase | 2023-11-24 | 13G | SPYRE THERAPEUTICS, INC SYRE | Perceptive Advisors LLC | 2,606,679 7.200% | 2,606,679 (New Position) | Filing History |
| 2023-12-11 5:21 pm Unchanged | 2023-12-07 | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 3,813,901 10.590% | 0 (Unchanged) | Filing History |
| 2023-12-01 4:15 pm Purchase | 2023-11-24 | 13G | SPYRE THERAPEUTICS, INC SYRE | Commodore Capital LP | 1,834,084 6.100% | 1,834,084 (New Position) | Filing History |
| 2023-11-29 5:08 pm Purchase | 2023-11-24 | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 3,813,901 12.700% | 3,030,301 (+386.72%) | Filing History |
| 2023-11-14 3:13 pm Purchase | 2023-09-08 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Deutsch Peter E. | 383,659 9.480% | 383,659 (New Position) | Filing History |
| 2023-07-28 09:01 am Purchase | 2023-07-19 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Polar Capital Holdings Plc | 157,448 5.020% | 157,448 (New Position) | Filing History |
| 2023-07-18 4:01 pm Purchase | 2023-07-06 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Logos Global Management LP | 254,000 8.100% | 254,000 (New Position) | Filing History |
| 2023-07-10 4:16 pm Purchase | 2023-06-28 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Venrock Healthcare Capital Partners III, L.P. | 319,200 9.990% | 319,200 (New Position) | Filing History |
| 2023-07-03 4:20 pm Purchase | 2023-06-22 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Affinity Asset Advisors, LLC | 299,080 9.230% | 299,080 (New Position) | Filing History |
| 2023-06-30 5:24 pm Purchase | 2023-06-22 | 13D | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Fairmount Funds Management LLC | 783,600 19.990% | 783,600 (New Position) | Filing History |
| 2023-06-30 4:20 pm Purchase | 2023-06-22 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | EcoR1 Capital Fund Qualified L.P. | 200,000 6.400% | 200,000 (New Position) | Filing History |
| 2023-06-30 4:00 pm Purchase | 2023-06-22 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Deep Track Capital, LP | 290,322 9.990% | 290,322 (New Position) | Filing History |